OzStar Therapeutics is developing a new combination therapy for the treatment of type 2 diabetes mellitus.

The Commercialisation Australia funding will be used to:

• strategically protect the intellectual property owned by OzStar;
• determine optimal commercialisation development pathway(s);
• conduct a market review and analysis; and
• develop a business plan.